DTIL
Price
$4.20
Change
-$0.10 (-2.33%)
Updated
Jun 30 closing price
Capitalization
46.57M
RPRX
Price
$36.03
Change
+$0.14 (+0.39%)
Updated
Jun 30 closing price
Capitalization
15.18B
36 days until earnings call
Interact to see
Advertisement

DTIL vs RPRX

Header iconDTIL vs RPRX Comparison
Open Charts DTIL vs RPRXBanner chart's image
Precision BioSciences
Price$4.20
Change-$0.10 (-2.33%)
Volume$158.58K
Capitalization46.57M
Royalty Pharma
Price$36.03
Change+$0.14 (+0.39%)
Volume$3.66M
Capitalization15.18B
DTIL vs RPRX Comparison Chart in %
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. RPRX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Buy and RPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (DTIL: $4.30 vs. RPRX: $35.87)
Brand notoriety: DTIL and RPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 129% vs. RPRX: 75%
Market capitalization -- DTIL: $46.57M vs. RPRX: $15.18B
DTIL [@Biotechnology] is valued at $46.57M. RPRX’s [@Biotechnology] market capitalization is $15.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileRPRX’s FA Score has 2 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • RPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, RPRX is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish while RPRX’s TA Score has 4 bullish TA indicator(s).

  • DTIL’s TA Score: 5 bullish, 5 bearish.
  • RPRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than RPRX.

Price Growth

DTIL (@Biotechnology) experienced а -10.23% price change this week, while RPRX (@Biotechnology) price change was +2.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

DTIL is expected to report earnings on May 15, 2025.

RPRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($15.2B) has a higher market cap than DTIL($46.6M). RPRX has higher P/E ratio than DTIL: RPRX (14.70) vs DTIL (4.53). RPRX YTD gains are higher at: 43.128 vs. DTIL (10.236). RPRX has higher annual earnings (EBITDA): 2.02B vs. DTIL (-16.57M). RPRX has more cash in the bank: 1.82B vs. DTIL (77.2M). DTIL has less debt than RPRX: DTIL (29.7M) vs RPRX (7.62B). RPRX has higher revenues than DTIL: RPRX (2.26B) vs DTIL (51.1M).
DTILRPRXDTIL / RPRX
Capitalization46.6M15.2B0%
EBITDA-16.57M2.02B-1%
Gain YTD10.23643.12824%
P/E Ratio4.5314.7031%
Revenue51.1M2.26B2%
Total Cash77.2M1.82B4%
Total Debt29.7M7.62B0%
FUNDAMENTALS RATINGS
DTIL vs RPRX: Fundamental Ratings
DTIL
RPRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
1
Undervalued
PROFIT vs RISK RATING
1..100
10028
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
8541
P/E GROWTH RATING
1..100
10057
SEASONALITY SCORE
1..100
n/a64

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RPRX's Valuation (1) in the Pharmaceuticals Major industry is in the same range as DTIL (31) in the Biotechnology industry. This means that RPRX’s stock grew similarly to DTIL’s over the last 12 months.

RPRX's Profit vs Risk Rating (28) in the Pharmaceuticals Major industry is significantly better than the same rating for DTIL (100) in the Biotechnology industry. This means that RPRX’s stock grew significantly faster than DTIL’s over the last 12 months.

RPRX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as DTIL (97) in the Biotechnology industry. This means that RPRX’s stock grew similarly to DTIL’s over the last 12 months.

RPRX's Price Growth Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for DTIL (85) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than DTIL’s over the last 12 months.

RPRX's P/E Growth Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for DTIL (100) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILRPRX
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
58%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
49%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 25 days ago
78%
Bullish Trend 7 days ago
52%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPLT8.010.06
+0.75%
Katapult Holdings
OMF57.000.35
+0.62%
OneMain Holdings
DEO100.840.40
+0.40%
Diageo plc
ANIP65.25-0.25
-0.38%
ANI Pharmaceuticals
HRTX2.07-0.07
-3.27%
Heron Therapeutics

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-2.33%
AXON - DTIL
46%
Loosely correlated
+1.14%
ORMP - DTIL
41%
Loosely correlated
+4.65%
ARRY - DTIL
39%
Loosely correlated
-8.39%
RENB - DTIL
36%
Loosely correlated
-1.30%
MURA - DTIL
34%
Loosely correlated
-0.40%
More

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+0.39%
AXON - RPRX
48%
Loosely correlated
+1.14%
MDGL - RPRX
31%
Poorly correlated
+0.63%
ARRY - RPRX
30%
Poorly correlated
-8.39%
DTIL - RPRX
30%
Poorly correlated
-2.33%
QURE - RPRX
29%
Poorly correlated
+0.43%
More